Digital RESI Pitch Session

Interested in Connecting? Please contact:
Dr. Steven Visuri
CEO
steven.visuri@stempharm.com

Message the company or request a 1:1 meeting here

Stem Pharm has developed a unique stem cell derived neural organoid model for pathway discovery and drug screening in CNS diseases. The “brain in a dish” model is applicable to studying neuroinflammatory pathways and discovery of new therapeutic approaches in neurodegenerative diseases and brain tumors such as glioblastoma. The technology can also be used for phenotypic screening of potential therapeutics for safety and efficacy. Stem Pharm is a spin out of the University of Wisconsin and is a recent graduate of the Illumina Accelerator.

Pitch Video